Literature DB >> 17543521

Discovery of inhibitors of the pentein superfamily protein dimethylarginine dimethylaminohydrolase (DDAH), by virtual screening and hit analysis.

Basil Hartzoulakis1, Sharon Rossiter, Herpreet Gill, Bernard O'Hara, Emily Steinke, Paul J Gane, Ramon Hurtado-Guerrero, James M Leiper, Patrick Vallance, Judith Murray Rust, David L Selwood.   

Abstract

An efficient process for the discovery of inhibitors of DDAH enzymes, without the requirement for high throughput screening, is described. Physicochemical filtering of a 308,000-compound library according to drug likeness followed by reciprocal nearest neighbour selection produced a representative subset of 35,000 compounds. Virtual screening on a dual processor PC using FlexX, followed by biological screening, identified two hit series. Similarity searches of commercial databases and chemical re-synthesis of pure compounds resulted in SR445 as an inhibitor of Pseudomonas aeruginosa DDAH at 2 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543521     DOI: 10.1016/j.bmcl.2007.04.095

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Screening for dimethylarginine dimethylaminohydrolase inhibitors reveals ebselen as a bioavailable inactivator.

Authors:  Thomas Linsky; Yun Wang; Walter Fast
Journal:  ACS Med Chem Lett       Date:  2011       Impact factor: 4.345

2.  A continuous, fluorescent, high-throughput assay for human dimethylarginine dimethylaminohydrolase-1.

Authors:  Thomas Linsky; Walter Fast
Journal:  J Biomol Screen       Date:  2011-09-15

Review 3.  Mechanistic similarity and diversity among the guanidine-modifying members of the pentein superfamily.

Authors:  Thomas Linsky; Walter Fast
Journal:  Biochim Biophys Acta       Date:  2010-07-21

4.  Development of a dimethylarginine dimethylaminohydrolase (DDAH) assay for high-throughput chemical screening.

Authors:  Yohannes T Ghebremariam; Daniel A Erlanson; Keisuke Yamada; John P Cooke
Journal:  J Biomol Screen       Date:  2012-03-29

5.  Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.

Authors:  Roman N Rodionov; Daryl J Murry; Sarah F Vaulman; Jeff W Stevens; Steven R Lentz
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

Review 6.  Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis.

Authors:  Tian Zhu; Shuyi Cao; Pin-Chih Su; Ram Patel; Darshan Shah; Heta B Chokshi; Richard Szukala; Michael E Johnson; Kirk E Hevener
Journal:  J Med Chem       Date:  2013-06-07       Impact factor: 7.446

7.  Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.

Authors:  Thomas W Linsky; Walter Fast
Journal:  Bioorg Med Chem       Date:  2012-08-03       Impact factor: 3.641

8.  A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide.

Authors:  Yohannes T Ghebremariam; Daniel A Erlanson; John P Cooke
Journal:  J Pharmacol Exp Ther       Date:  2013-10-17       Impact factor: 4.030

Review 9.  Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

Authors:  Anna Czarnecka; Krzysztof Milewski; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2016-11-25       Impact factor: 3.996

Review 10.  The Second Life of Methylarginines as Cardiovascular Targets.

Authors:  Natalia Jarzebska; Arduino A Mangoni; Jens Martens-Lobenhoffer; Stefanie M Bode-Böger; Roman N Rodionov
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.